China's National Medical Products Administration (NMPA) has granted conditional market approval to CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac Biotech. It is the second domestically developed COVID-19 vaccine to receive conditional market approval in the country.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3